Justin A. Budka

ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells

Joshua P. Plotnik, Justin A. Budka, Mary W. Ferris et al. · Nucleic Acids Research · 2014 · 122 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17

Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma

Frederick L. Locke, Simone Filosto, Justin Chou et al. · Nature Medicine · 2024 · 108 citations · Full text

Medicine, Immunology, Oncology +11

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma

Nur P. Damayanti, Justin A. Budka, Heba Khella et al. · Clinical Cancer Research · 2018 · 94 citations

Medicine, Cancer Biology, Oncology +13

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Remi Adelaiye‐Ogala, Justin A. Budka, Nur P. Damayanti et al. · Cancer Research · 2017 · 74 citations

Medicine, Oncology, Pharmacology +17

An Interaction with Ewing’s Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer

Vivekananda Kedage, Nagarathinam Selvaraj, Taylor R. Nicholas et al. · Cell Reports · 2016 · 53 citations · Full text

Medicine, Genetics, Oncology +17